Robert E Belliveau Md Inc is categorized under Doctors in Newburyport, MA and active since 2008.
Robert E Belliveau Md Inc was established in 2008, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Doctors business, which does work in the B2C market, and is classified as a Doctors, under code number 621111 by the NAICS.
If you are seeking more information, feel free to contact Robert E Belliveau at the company’s single location by writing to 25 Highland Avenue, Newburyport, Massachusetts MA 01950 or by phoning (978) 463-1101. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Robert E Belliveau Md Inc |
| Contact Person: | Robert E Belliveau |
| Address: | 25 Highland Avenue, Newburyport, Massachusetts 01950 |
| Phone Number: | (978) 463-1101 |
| Website Address: | ma-newburyport.doctors.at |
| Annual Revenue (USD): | $100.000 to $499.999 |
| Founded: | 2008 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Doctors |
| SIC Code: | 8011 |
| NAICS Code: | 621111 |
| Share This Business: |
Robert E Belliveau Md Inc was started in 2008 to provide professional Doctors under the SIC code 8011 and NAICS code 621111. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact Robert E Belliveau for inquiries that concern Robert E Belliveau Md Inc by calling the company number (978) 463-1101, as your correspondence is most welcome. Additionally, the physical location of the single location of Robert E Belliveau Md Inc can be found at the coordinates 42.814685,-70.890592 as well as the street address 25 Highland Avenue in Newburyport, Massachusetts 01950.
For its online presence, you may visit Robert E Belliveau Md Inc’s website at ma-newburyport.doctors.at and engage with its social media outlets through on Twitter and on Facebook.